Venrock Healthcare Capital Partners III L.P. 13D and 13G filings for Milestone Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 8:56 pm Sale |
2023-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Venrock Healthcare Capital Partners III L.P. | 925,048 2.800% |
-1,283,764 (-58.12%) |
Filing |
| 2023-02-14 4:07 pm Purchase |
2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Venrock Healthcare Capital Partners III L.P. | 2,208,812 6.400% |
136,803 (+6.60%) |
Filing |
| 2022-09-19 9:14 pm Purchase |
2022-09-09 | 13G | Milestone Pharmaceuticals Inc. MIST |
Venrock Healthcare Capital Partners III L.P. | 2,072,009 6.900% |
2,072,009 (New Position) |
Filing |